Caxton Corp Catalyst Pharmaceuticals, Inc. Transaction History

Caxton Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $140,096 - $264,140	-72,967 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $110,056 - $148,047	39,166 Added 115.87%	72,967 $276,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $5,148 - $8,747	-2,278 Reduced 6.31%	33,801 $0
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $7,095 - $11,905	2,969 Added 8.97%	36,079 $86,000
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $83,106 - $145,684	33,110	33,110 $129,000

348

98.4M

13.4K

11.7K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.54B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

Stay updated on Caxton Corp with notifications on news.